Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 1.405
+0.080 (6.04%)
Feb 6, 2026, 1:16 PM CET
Stenocare Revenue
Stenocare had revenue of 1.92M DKK in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 5.67M, up 183.98% year-over-year. In the year 2024, Stenocare had annual revenue of 2.23M, down -40.60%.
Revenue (ttm)
5.67M
Revenue Growth
+183.98%
P/S Ratio
10.09
Revenue / Employee
709.22K
Employees
8
Market Cap
57.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.23M | -1.53M | -40.60% |
| Dec 31, 2023 | 3.76M | -731.58K | -16.30% |
| Dec 31, 2022 | 4.49M | 2.60M | 137.54% |
| Dec 31, 2021 | 1.89M | 1.69M | 852.38% |
| Dec 31, 2020 | 198.45K | -4.74M | -95.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 309.06B |
| Coloplast | 27.87B |
| Genmab | 24.48B |
| ALK-Abelló | 6.08B |
| Scandinavian Medical Solutions | 245.44M |
| BioPorto | 36.56M |
| Monsenso | 10.80M |
| ViroGates | 8.11M |